Prof. Brian Tomlinson
Consultant (honorary)
(Clinical Pharmacology)
Professor Tomlinson has conducted over 80 bioequivalence and 20 Phase I clinical trials, including first-in-man studies, in the past 30 years, with special interests in pharmacogenomics and ethnic differences in drug responses, lipid disorders, hypertension and diabetes.